Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients

Immunology Letters

Volumn 150, Issue 1-2, 2013, Pages 116-122

  Li, Fu Jun ^a   Zhang, Ying ^a   Jin, Guang Xin ^a   Yao, Lei ^a   Wu, De Quan ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CD8; Hepatitis B virus; Hepatocellular carcinoma; LAG 3; Tumor infiltrating lymphocytes

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE ACTIVATION GENE 3; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

ADULT; ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 84874406566     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.12.004     Document Type: Article

References (32)

1. Tan A., Yeh S.H., Liu C.J., Cheung C., Chen P.J. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008, 28:175-188.
2. Qiu S.J., Lu L., Qiao C., Wang L., Wang Z., Xiao X., et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol 2005, 131:429-438.
3. Ilan Y., Gabay E., Amit G., Feder R., Galun E., Adler R., et al. Suppression of human hepatoma in mice through adoptive transfer of immunity to hepatitis B surface antigen. J Hepatol 1997, 27:170-175.
4. Gotsman I., Alper R., Klein A., Rabbani E., Engelhardt D., Ilan Y. Induction oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer 2002, 94:406-414.
5. Chun E., Lee J., Cheong H.S., Lee K.Y. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice. J Immunol 2003, 170:1183-1190.
6. Triebel F., Jitsukawa S., Baixeras E., Roman-Roman S., Genevee C., Viegas-Pequignot E., et al. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 1990, 171:1393-1405.
7. Workman C.J., Dugger K.J., Vignali D.A.A. Molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol 2002, 169:5392-5395.
8. Workman C.J., Vignali D.A. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003, 33:970-979.
9. Maçon-Lemaître L., Triebel F. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells. Immunology 2005, 115:170-178.
10. Andreae S., Piras F., Burdin N., Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002, 168:3874-3880.
11. Grosso J.F., Goldberg M.V., Getnet D., Bruno T.C., Yen H.R., Pyle K.J., et al. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8+ T cells. J Immunol 2009, 182:6659-6669.
12. Demeure C.E., Wolfers J., Martin-Garcia N., Gaulard P., Triebel F. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. Eur J Cancer 2001, 37:1709-1718.
13. Shi M., Qian S., Chen W.W., Zhang H., Zhang B., Tang Z.R., et al. B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2007, 147:277-286.
14. Xu D., Gu P., Pan P.Y., Li Q., Sato A.I., Chen S.H. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation. Int J Cancer 2004, 109:499-506.
15. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000, 191:1269-1280.
16. Zhang Y., Wang H.B., Chi L.J., Wang W.Z. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol Lett 2009, 122:52-57.
17. Gandhi M.K., Lambley E., Duraiswamy J., Dua U., Smith C., Elliott S., et al. Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 2006, 108:2280-2289.
18. Matsuzaki J., Gnjatic S., Mhawech-Fauceglia P., Beck A., Miller A., Tsuji T., et al. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A 2010, 107:7875-7880.
19. Workman C.J., Rice D.S., Dugger K.J., Kurschner C., Vignali D.A. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur J Immunol 2002, 32:2255-2263.
20. Grosso J.F., Kelleher C.C., Harris T.J., Maris C.H., Hipkiss E.L., De Marzo A., et al. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 2007, 117:3383-3392.
21. Redmond W.L., Sherman L.A. Peripheral tolerance of CD8 T lymphocytes. Immunity 2005, 22:275-284.
22. Shin H., Wherry E.J. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007, 19:408-415.
23. Gehring A.J., Ho Z.Z., Tan A.T., Aung M.O., Lee K.H., Tan K.C., et al. Profile of tumor antigen-specific CD8+ T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2009, 137:682-690.
24. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005, 5:263-274.
25. Workman C.J., Vignali D.A. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol 2005, 174:688-695.
26. Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003, 33:3117-3126.
27. Gajewski T.F., Fallarino F., Fields P.E., Rivas F., Alegre M.L. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol 2001, 166:3900-3907.
28. Huard B., Gaulard P., Faure F., Hercend T., Triebel F. Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand. Immunogenetics 1994, 39:213-217.
29. Kisielow M., Kisielow J., Capoferri-Sollami G., Karjalainen K. Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells. Eur J Immunol 2005, 35:2081-2088.
30. Workman C.J., Wang Y., El Kasmi K.C., Pardoll D.M., Murray P.J., Drake C.G., et al. LAG-3 regulates plasmacytoid dendritic cell homeostasis. J Immunol 2009, 182:1885-1891.
31. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009, 10:29-37.
32. Huang C.T., Workman C.J., Flies D., Pan X., Marson A.L., Zhou G., et al. Role of LAG-3 in regulatory T cells. Immunity 2004, 21:503-513.